First Trust NYSE Arca Biotechnology Index Fund
107 hedge funds and large institutions have $297M invested in First Trust NYSE Arca Biotechnology Index Fund in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 58 reducing their positions, and 37 closing their positions.
3% more call options, than puts
Call options by funds: $876K | Put options by funds: $849K
17% less funds holding
Funds holding: 129 → 107 (-22)
37.62% less ownership
Funds ownership: 71.68% → 34.06% (-38%)
50% less funds holding in top 10
Funds holding in top 10: 10 → 5 (-5)
54% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 37
74% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 58
88% less capital invested
Capital invested by funds: $2.46B → $297M (-$2.16B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.55M |
| 2 |
Jane Street
New York
|
+$7M |
| 3 |
TH
Timber Hill
Greenwich,
Connecticut
|
+$2.57M |
| 4 |
VF
Virtu Financial
New York
|
+$2.56M |
| 5 |
SG Americas Securities
New York
|
+$2.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$1.21B |
| 2 |
Morgan Stanley
New York
|
-$205M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$128M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$64.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$56M |
FBT Hedge Fund Activity: Q1 2016 in Review
107 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q1 2016, worth a combined $297M — down 88% from $2.46B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of FBT and 17 opened new positions — a net loss of 20 holders — while 58 trimmed existing stakes and 15 added.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $7.55M. The largest seller was First Trust Advisors, exiting entirely with an estimated $1.21B sold.
- 107 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q1 2016, down from 129 in Q4 2015.
- Funds reported $297M of First Trust NYSE Arca Biotechnology Index Fund stock for Q1 2016, down 88% quarter-over-quarter.
- 17 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q1 2016 and 37 closed out, a net change of -20 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q1 2016 was Tower Research Capital (TRC), an estimated $7.55M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q1 2016 was First Trust Advisors, an estimated $1.21B sold.
Based on aggregated 13F filings for Q1 2016.